Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Sale Of Investment
$416.70 Mil (TTM As of Sep. 2014)

Synageva BioPharma Corp's sale of investment for the three months ended in Sep. 2014 was $160.50 Mil. It means Synageva BioPharma Corp gained $160.50 Mil from selling investments. Synageva BioPharma Corp's sale of investment for the trailing twelve months (TTM) ended in Sep. 2014 was $416.70 Mil.

Compared with last quarter ($95.05 Mil in Jun. 2014 ), Synageva BioPharma Corp gained more money from selling investments in Sep. 2014 ($160.50 Mil).


Definition

Sale of Investments represents cash inflow on the sale of investments in securities.

Synageva BioPharma Corp SaleOfInvestment for the trailing twelve months (TTM) ended in Sep. 2014 was 70.5 (Dec. 2013 ) + 90.65 (Mar. 2014 ) + 95.05 (Jun. 2014 ) + 160.5 (Sep. 2014 ) = $416.70 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Purchase of Investment, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
SaleOfInvestment 66.7641.2814.5340.5458.5716.331.020.000.00271.95

Synageva BioPharma Corp Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
SaleOfInvestment 0.000.000.0043.0075.7082.7570.5090.6595.05160.50
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK